Oak Longevity vs WeightWatchers (Sequence): Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Oak Longevity beats WeightWatchers (Sequence) overall, scoring 7.5/10 vs 7.4/10. WeightWatchers (Sequence) is more affordable at $74/mo vs $130/mo. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound. Choose WeightWatchers (Sequence) for users who want glp-1 medication combined with the weightwatc.
A side-by-side comparison of Oak Longevity and WeightWatchers (Sequence) covering pricing, scores, medication types, insurance, and more to help you decide.
Oak Longevity
#23 of 42Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing — patients pay each month manually rather than auto-renew.
Visit Oak LongevityWeightWatchers (Sequence)
#26 of 42WeightWatchers' clinical weight management arm (acquired from Sequence) restructured in 2026: $74/mo ongoing membership (first 2 months $25 intro) + medication billed separately. Intro medication pricing $199/mo first 2 months, $349/mo ongoing. Added Saxenda (liraglutide) to the lineup.
Visit WeightWatchers (Sequence)| Feature | Oak Longevity | WeightWatchers (Sequence) |
|---|---|---|
| Our Score | 7.5/10 | 7.4/10 |
| Starting Price | $130/mo | $74/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | Yes |
| Best For | Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin) | Users who want GLP-1 medication combined with the WeightWatchers program and community — restructured 2026 with decoupled membership + medication pricing |
| Ranking | #23 | #26 |
Pros & Cons Compared
Oak Longevity
Pros
- +$130/mo for compounded semaglutide is among the cheapest entries on the market — Sprout Health ($99) and Sesame Care ($99) are lower, but Oak undercuts most mid-tier platforms
- +Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
- +No-subscription model — patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
- +Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
- +Money-back guarantee if not approved by physician — useful safety net for borderline-eligibility patients
- +Free shipping and free health coaching included in every program
Cons
- −Brand-name pricing ($1,200-$1,500/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo, LillyDirect Zepbound $299/mo. Never buy brand-name through Oak
- −No published lab panels, no specialty (obesity medicine) physicians disclosed — clinical depth is shallow
- −'Up to 50% cheaper than competitors' marketing claim is unverified and inconsistent — depends on which competitor and which medication tier
- −'Longevity' framing pushes users toward add-on products (NAD+, Sermorelin, Tesamorelin) that have limited clinical evidence for weight loss specifically
- −Newer brand without disclosed company history, founding date, or executive team on landing pages
- −Three-month plans are billed upfront — pricing transparency is good, but commit-up-front is a friction point for users testing the platform
WeightWatchers (Sequence)
Pros
- +Combines GLP-1 medication with WeightWatchers' proven points system and community support
- +Insurance accepted for medication — can reduce costs significantly with qualifying plans
- +Decades of brand trust and weight loss expertise applied to clinical medication management
- +Access to WW community, workshops, and digital tools alongside medication
Cons
- −$269/mo without insurance is expensive for what's included clinically
- −The WW program integration adds complexity that medication-only users won't value
- −The Sequence acquisition is still integrating — some operational inconsistencies remain
- −Less medication flexibility than pure-play GLP-1 platforms
Our Verdict
Oak Longevity edges out WeightWatchers (Sequence) with a score of 7.5/10 vs 7.4/10. If budget is your priority, WeightWatchers (Sequence) starts at $74/mo compared to Oak Longevity's $130/mo. WeightWatchers (Sequence) accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin). Choose WeightWatchers (Sequence) if you want: users who want glp-1 medication combined with the weightwatchers program and community — restructured 2026 with decoupled membership + medication pricing.